Evidence-Based Assessment for Child and Adolescent Psychiatry: Better Tools for Better Decisions and Outcomes
Participants learn about evidence-based assessment (EBA) to support diagnostic and treatment decision making and to improve patient care. (Source: Journal of the American Academy of Child and Adolescent Psychiatry)
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2018 Category: Psychiatry Authors: Cathryn A. Galanter, Eric A. Youngstrom Tags: Institute 2 Source Type: research

2.1 Diagnostic Interviews and Rating Scales 101: Supporting Your Clinical Decision Making
Rating scales and standardized diagnostic interviews can support clinicians ’ decision making. When clinicians rely on their clinical judgment alone, they may be prone to biases leading to misdiagnosis and missed diagnoses. This talk reviews interviews and scales that clinicians might use in their practice. (Source: Journal of the American Academy of Child and Adolescent Psychiatry)
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2018 Category: Psychiatry Authors: Cathryn A. Galanter Source Type: research

2.2 Evidence-Based Screening and Assessment in Primary Care: A Decade of Experience
Most practicing pediatricians report that they received little training in the diagnosis and treatment of common mental disorders during residency, apart from whatever they obtained during a 1-month rotation in developmental behavioral pediatrics or in their continuity clinics. Not surprisingly, in their subsequent practice settings, they are unprepared to diagnosis and manage common conditions, such as depression, anxiety, disruptive behavioral disorders, and even ADHD. To address this problem, since 2006, the REACH Institute (www.TheREACHInstitute.org) has conducted more than 80 six-month-long training sessions for nearl...
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2018 Category: Psychiatry Authors: Peter S. Jensen Source Type: research

2.3 Evidence-Based Identification of Depression
Depression is relatively common among youth and is associated with impairment and negative outcomes, including suicide. In spite of its prevalence and consequences, depression in youth often goes undiagnosed according to the US Preventive Services Task Force. Numerous factors can interfere with accurate diagnosis: symptoms may be misattributed to other disorders or “normal” behavior; a change in functioning may not seem to warrant professional help; or comorbid conditions may obscure a depressive disorder. (Source: Journal of the American Academy of Child and Adolescent Psychiatry)
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2018 Category: Psychiatry Authors: Anna Van Meter, Eric Youngstrom Source Type: research

2.4 Evidence-Based Assessment and Rating Scales at the Beginning, Middle, and End of Treatment
The goal of this session is to provide a brief overview of evidence-based assessment, emphasizing the following: 1) 3 major phases of assessment over the course of treatment; 2) an overview of several rating scales and methods for identifying which to use in your practice; and 3) new ways that rating scales can add to prediction, prescription of treatment, and process measurement. (Source: Journal of the American Academy of Child and Adolescent Psychiatry)
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2018 Category: Psychiatry Authors: Eric Youngstrom Source Type: research

2.5 Evidence-Based Assessment to Improve Psychopharmacological Treatment Outcomes
The goals of this session are as follows: 1) to review the rationale for and use of measure-based care, which includes evidence-based assessments and treatment practice parameters; and 2) to monitor psychopharmacological outcomes in youth with depression. (Source: Journal of the American Academy of Child and Adolescent Psychiatry)
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2018 Category: Psychiatry Authors: Graham J. Emslie Source Type: research

2.6 The Monitoring of Adverse Events During Psychopharmacological Treatment
Psychiatric medications that are prescribed to children and adolescents can be associated with risks. The purpose of this presentation is to provide a review of monitoring methods that might be used when prescribing psychotropic medications to pediatric patients. (Source: Journal of the American Academy of Child and Adolescent Psychiatry)
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2018 Category: Psychiatry Authors: Robert L. Findling Source Type: research

Gender Dysphoria Across Development: Multidisciplinary Perspectives on the Evidence, Ethics, and Efficacy of Gender Transition
The evidence base for best practices for gender dysphoria in children and adolescents is growing; however, children and adolescents are presenting with needs that have outpaced the scientific advancement of knowledge. Despite the existence of clinical guidelines, limited training on these issues leads to a lack of clinical competence among providers. There are numerous ethical dilemmas that exist across development, and multidisciplinary collaboration is crucial to provide care that sometimes involves interventions that lead to irreversible anatomical changes. (Source: Journal of the American Academy of Child and Adolescent Psychiatry)
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2018 Category: Psychiatry Authors: Scott Leibowitz Tags: Institute 3 Source Type: research

3.1 Gender Dysphoria: Ethics, Evidence, and Efficacy of Transition Across Development
The evidence base for best practices for gender dysphoria in children and adolescents is growing; however, children and adolescents are presenting with needs that have outpaced the scientific advancement of knowledge. Prepubertal children with gender-related concerns present unique ethical dilemmas to providers when parents seek guidance on how to best address their child ’s gender identity and/or gender expression, with regard to socially transitioning to another gender. Pubertal suppression, indicated for some peripubertal adolescents with gender-related concerns, introduces another set of ethical dilemmas. (Source...
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2018 Category: Psychiatry Authors: Scott Leibowitz Source Type: research

3.2 Biological Determinants of Gender Identity
In the last 10 to 15 years, compelling data have emerged supporting the concept that gender identity is not simply a psychosocial construct but likely reflects a complex interplay of biological, environmental, and cultural factors. The principal objective of this presentation is to review scientific evidence in support of biological underpinnings of gender identity. (Source: Journal of the American Academy of Child and Adolescent Psychiatry)
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2018 Category: Psychiatry Authors: Stephen Rosenthal Source Type: research

3.3 Hormone Management of Transgender Youth and Adolescents
Pioneering work from the Netherlands over the last 30 years has informed current models of medical care for gender-nonconforming/transgender youth, as summarized in the most recent editions of the Endocrine Society ’s Clinical Practice Guidelines and the World Professional Association of Transgender Health’s Standards of Care. The principal objectives will be to understand the use of pubertal blockers and gender-affirming sex hormones in youth with gender incongruence. (Source: Journal of the American Academy of Child and Adolescent Psychiatry)
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2018 Category: Psychiatry Authors: Stephen Rosenthal Source Type: research

3.4 Gender Confirming Surgical Care in Adolescence: Evidence, Timing, Options, and Outcomes
Requests for gender- confirming surgical procedures have dramatically increased, particularly for adolescents with gender dysphoria. Although there is mounting evidence that surgery is safe, effective, and leads to improved quality of life for transgender adults, there are significant ethical challenges with respect to offering irreversible interventions for minors. Surgeons depend on mental health providers to assess for eligibility and readiness criteria for certain irreversible procedures in minors, particularly chest masculinization ( “top surgery”) for the transmasculine population. (Source: Journal of the...
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2018 Category: Psychiatry Authors: Loren Schechter Source Type: research

3.5 Prepubertal Gender Diverse Children: Using Evidence and Experience to Understand the Pros and Cons of Social Transition
An increasing number of children are socially transitioning to live as members of a gender that does not align with their sex at birth by changing their first names, pronouns, hair styles, and wardrobes. Yet little scientific research has been published tracking this cohort to understand the impact of these transitions on their development and well-being. Historical longitudinal data indicate that some children with gender dysphoria will no longer remain so in adolescence, adding to the complexity of the decision. (Source: Journal of the American Academy of Child and Adolescent Psychiatry)
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2018 Category: Psychiatry Authors: Kristina Olson Source Type: research

3.6 The Psychological Developmentally-Informed Assessment for Gender Dysphoric Youth: Rationale for a Comprehensive Approach
Research and clinical guidelines recommend gender affirming medical interventions as medically and psychologically necessary treatment for many individuals who experience gender dysphoria. Current standards support an “informed consent” process as one option for transgender adults. Adolescent development literature and guidelines for transgender youth suggest the importance of an assessment for individuals in this unique developmental stage to optimize outcomes. Much of the existing evidence on the psychologi cal benefits of irreversible medical interventions in these youth has been done in the Amsterdam Dutch ...
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2018 Category: Psychiatry Authors: Laura Edwards-Leeper Source Type: research

3.7 Gender Dysphoria and Co-Ocurring Psychiatric Disorders: The Evidence and Approach
Gender variance and dysphoria are present across all classes, ethnicities, and experiences, including among those with severe and chronic mental illnesses. In these, our most vulnerable populations, adequate assessment and treatment of gender dysphoria often are overlooked despite evidence that appropriate treatment of gender dysphoria leads to improvement in psychological functioning. (Source: Journal of the American Academy of Child and Adolescent Psychiatry)
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2018 Category: Psychiatry Authors: Aron Janssen Source Type: research

3.8 Identical Twins, Fraternal Genders: A Family ’s Perspective on Gender Transition
Discussions on social transitioning, pubertal suppression, cross-sex hormones, and surgical procedures present challenging topics. In addition, encouraging families to see gender-related concerns as a manageable component of everyday family life is important in maintaining a stable family environment. (Source: Journal of the American Academy of Child and Adolescent Psychiatry)
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2018 Category: Psychiatry Authors: Melissa McLaren Source Type: research

Lifelong Learning Institute: Module 15: Relevant Clinical Updates for Child and Adolescent Psychiatrists
AACAP ’s Lifelong Learning Committee has developed a series of modules to assist members in staying up to date on current issues within the field of child and adolescent psychiatry and in fulfilling lifelong learning and self-assessment requirements of Maintenance of Certification (MOC). This Institute reviews Lifelong Learning Module 15. The articles selected for this year’s module address ethical dilemmas, among other timely topics. The articles are relevant to every practicing child and adolescent psychiatrist. (Source: Journal of the American Academy of Child and Adolescent Psychiatry)
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2018 Category: Psychiatry Authors: Jeffrey I. Hunt, Sandra B. Sexson Tags: Institute 4 Source Type: research

4.1 Transition to Adulthood, Telepsychiatry, and Child and Adolescent Psychiatry ’s Therapeutic Identity: Treatment of Anxiety, Dmdd, and Weight Gain on Antipsychotics
The goals of this session are as follows: 1) to review the  recent literature on the transition to adulthood for special populations of youth; 2) to review the evolving identity of the early career psychiatrist; 3) to review treatment updates regarding anxiety disorders, DMDD, and weight gain in those youth on antipsychotic drugs; and finally, 4) to review the potential of telepsychiatry to address unmet treatment needs. (Source: Journal of the American Academy of Child and Adolescent Psychiatry)
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2018 Category: Psychiatry Authors: John T. Walkup Source Type: research

4.2 What ’s New in Substance Use Disorders and ADHD in Adolescents and Adults?
The goal of this session is to review articles chosen by the Lifelong Learning Committee that address current concepts and understanding in the following areas: 1) diagnosis of ADHD in adults; 2) longer-term course of ADHD and its relationship to treatment; 3) facilitating youth who have had special education into adulthood; and 4) novel substances of misuse in adolescents. (Source: Journal of the American Academy of Child and Adolescent Psychiatry)
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2018 Category: Psychiatry Authors: Timothy Wilens Source Type: research

4.3 Identification and Treatment of Mental Disorders in Early Childhood
There has been an increasing body of evidence to inform the validation and identification of mental disorders in early childhood. (Source: Journal of the American Academy of Child and Adolescent Psychiatry)
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2018 Category: Psychiatry Authors: Joan Luby Source Type: research

4.4 Environments, Epigenes, Brains, and Behavior
The goal of this session is to review articles chosen by the Lifelong Learning Committee addressing current concepts and understanding on topical areas of brain development, health promotion and illness prevention, and genetic testing approaches. These articles focus on the following: 1) the relationship between brain development and health and illness during the transitional ages (ages 14 –25 years); 2) DREAMers (Development, Relief and Education for Alien Minors) living in this country and the cultural and clinical implications; 3) novel approaches to prevention and intervention in preschool-aged children; and 4) a...
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2018 Category: Psychiatry Authors: James J. Hudziak Source Type: research

4.5 The How To ’s: The Use and Monitoring of Atypical Antipsychotics in Youth
The goal of this session is to review articles chosen by AACAP ’s Lifelong Learning Committee that share a common focus on the use and monitoring of atypical antipsychotic drugs in children and adolescents. (Source: Journal of the American Academy of Child and Adolescent Psychiatry)
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2018 Category: Psychiatry Authors: Jean A. Frazier Source Type: research

4.6 Co-Occurring Medical Issues in Child and Adolescent Psychiatry
The goal of this session is to review articles chosen by AACAP ’s Lifelong Learning Committee highlighting topics important for child and adolescent psychiatrists in the integrated management of patients with co-occurring medical and mental health issues. Important topics include the following: 1) eating disorders; 2) hormonal contraception; 3) sports-related concussion; 4) delirium in pediatric critical care; 5) autoimmune encephalitis; and 6) PANS. (Source: Journal of the American Academy of Child and Adolescent Psychiatry)
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2018 Category: Psychiatry Authors: Matthew Dean Willis Source Type: research

Research Institute: Treatment Updates in Pediatric Depression and Suicidality
Depression affects approximately 25% of adolescents. Suicide is the second leading cause of death in adolescents and young adults. This Institute will provide updates from a multidisciplinary team regarding the latest clinical research advancements in the assessment and treatment of child and adolescent depression and suicidality. (Source: Journal of the American Academy of Child and Adolescent Psychiatry)
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2018 Category: Psychiatry Authors: Anne L. Glowinski, Michael Bloch Tags: Institute 5 Source Type: research

5.1 Update: Antidepressant Trials for Depression in Children and Adolescents
This presentation will provide a review and update on antidepressant RCTs for depression in children and adolescents. (Source: Journal of the American Academy of Child and Adolescent Psychiatry)
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2018 Category: Psychiatry Authors: Karen Dineen Wagner Source Type: research

5.2 Ssris and Suicidality: Cause or Cure?
Significant concerns about the relationship between the use of SSRIs and suicidal risk in adolescents have emerged over the past decade. This presentation will review the extent of the relationship; examine the risks versus the benefits of SSRIs for adolescent depression; discuss the possible explanations for the relationship; and make recommendations for clinical management, public health messaging, and future research. (Source: Journal of the American Academy of Child and Adolescent Psychiatry)
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2018 Category: Psychiatry Authors: David A. Brent Source Type: research

5.3 Ketamine Across the Lifespan: An Emerging Treatment for Depression and Suicidality
Approximately 25% of adolescents experience a major depressive episode. Suicide is the second leading cause of death in individuals aged 15 –24 years. Effective treatments for adolescents include pharmacotherapy with SSRIs and specific psychotherapies. However, these treatments are not effective for many patients, and their therapeutic action is typically delayed when they work. In this session, attendees will do the following: 1) und erstand the evidence base for the use of ketamine, a novel rapid-acting antidepressant, in adult depressive disorders and suicidal ideation; 2) become familiar with initial evidence exa...
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2018 Category: Psychiatry Authors: Michael Bloch, Jennifer Dwyer Source Type: research

5.4 Computerized Adaptive Screen for Teen Suicide Risk: Development and Three-Month Prediction of Suicide Attempts
Suicide is the second leading cause of death among youth ages 12 to 17 years in the United States. However, many adolescents at high risk for suicide go unrecognized and untreated. Evidence-based screening and recognition strategies are needed. Attendees at this session will be able to do as follows: 1) learn how the computerized adaptive screen for teen suicide risk (CAS-Teen Suicide Risk) was developed in the Emergency Department Screen for Teens at Risk for Suicide (ED-STARS) national study; and 2) understand the sensitivity and specificity of screen questions for the prediction of suicide attempts within 3 months. (Sou...
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2018 Category: Psychiatry Authors: Cheryl King, Jacqueline Grupp-Phelan, David A. Brent, T. Charles Casper Source Type: research

5.5 Youth Suicide: How Gender, Sexual Orientation, and Gender-Nonconforming Status Shape Risk and Inform Intervention Strategies
Suicide has recently risen to the second leading cause of death in individuals ages 10 –24 years. For every completed suicide, there are an estimated 8–25 attempts, with self-injury even more common. Adolescent females are more likely to engage in suicidal and self-harming behaviors, whereas suicide death is more common among adolescent males. Sexual minority youth endorse higher rates of self-harm, suicidal ideation, and suicide attempts, with gender-diverse youth reporting 2–3 times the rate of suicidal thoughts compared with cis-gender peers. (Source: Journal of the American Academy of Child and Adolescent Psychiatry)
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2018 Category: Psychiatry Authors: Elizabeth McCauley, Molly Adrian, Amy Curtis Source Type: research

Innovative Interventions in Child and Adolescent Psychiatry: Extending Our Reach
The participant will be able to do the following: 1) discuss how the PAX-Good Behavior Game, a preventive intervention, works in elementary schools and how the strategy can be scaled up for more general benefit; 2) extend general mental health interventions directly through the use of internet technology [applications (Apps) or online computerized treatment] and telemedicine; 3) implement a relatively brief psychological intervention to enhance treatment of depression that does not require the specialized training of CBT and interpersonal psychotherapy; 4) describe interventions for the more seriously impairing internalizi...
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2018 Category: Psychiatry Authors: Gabrielle A. Carlson Tags: Institute 6 Source Type: research

6.1 Brief Psychosocial Intervention for Teens With Major Depression
In the United Kingdom, there is an increasing demand for child and adolescent mental health services. The UK National Institute for Health and Care Excellence (NICE) recommends specialized psychological therapy as first-line treatment for depression; however, this is an expensive and relatively scarce resource. There is an urgent need to increase access to cost-effective psychological treatments. In this presentation, attendees will be able to do the following: 1) learn about the key components of a manualized brief psychosocial intervention (BPI) for adolescents with depressive disorder; 2) be informed about the delivery ...
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2018 Category: Psychiatry Authors: Bernadka W. Dubicka Source Type: research

6.2 Therapy Apps: What They Can and Can ’t Do
By the end of this session, the attendee will understand the following: 1) the spectrum of behavioral intervention technologies available in child and adolescent mental health; 2) the rationale and evidence for these interventions; and 3) how these might be implemented into the practice of child psychiatry, including strengths and limitations. (Source: Journal of the American Academy of Child and Adolescent Psychiatry)
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2018 Category: Psychiatry Authors: Sally N. Merry Source Type: research

6.3 Talk the Talk: Intensive Behavioral Treatment for Children With Selective Mutism
In this session, we describe the following: 1) the evaluation process highlighting novel approaches, such as use of video samples and observation of the parent-child interaction for children with selective mutism (SM); and 2) a way that clinicians can transport components of intensive treatment to their practice. (Source: Journal of the American Academy of Child and Adolescent Psychiatry)
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2018 Category: Psychiatry Authors: Rachel Busman, Harold S. Koplewicz Source Type: research

6.4 Ketamine: An Emerging Treatment for Adolescent Depression
MDD is a significant pediatric health problem, with a point prevalence of up to 8% and a lifetime prevalence approaching 25% by the end of adolescence. Suicide is the second leading cause of death in youths age 15 –24 years. Although we currently have several effective pharmacological and psychological treatments for depression, treatments that work better and faster are urgently needed. We plan to review the evidence base for ketamine as an emerging treatment for depression and discuss our experience using ketamine in adolescent populations. (Source: Journal of the American Academy of Child and Adolescent Psychiatry)
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2018 Category: Psychiatry Authors: Michael Bloch, Jennifer Dwyer Source Type: research

6.5 The Good Behavior Game: How It Works and What It Does for Psychiatric Disorders
Pediatric psychiatric disorders are increasing every 2 years. Can a fun, well-tested classroom game invented in 1969 reduce these disorders? The answer is “yes.” In this session, participants will learn the following: 1) how the game works; 2) the breadth of longitudinal outcomes; and 3) how to scale up the game. The game is played during regular school instruction. Teachers divide children into 2 to 5 teams per classroom, balancing teams with hig h-achieving, shy, and disruptive students. The teams work to increase PAX (“peace, productivity, health, and happiness”). (Source: Journal of the American...
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2018 Category: Psychiatry Authors: Alan A. Axelson Source Type: research

6.6 Telemental Health: Facilitating Innovative Mental Health Interventions
Attendees will learn the following: 1) the expanding uses of telemental health (TMH) to increase access to and capacity for the delivery of evidence-based mental health interventions; 2) models of care that are most amenable to TMH delivery; 3) the practical steps of establishing a TMH clinic; and 4) whether TMH is right for their practice. (Source: Journal of the American Academy of Child and Adolescent Psychiatry)
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2018 Category: Psychiatry Authors: David E. Roth Source Type: research

Developmental Considerations in Substance Use Disorders: From Pregnancy to Puberty and Beyond
The implementation of developmentally informed clinical interventions for individuals and families struggling with substance use disorders (SUDs) is essential in child and adolescent psychiatric practice. (Source: Journal of the American Academy of Child and Adolescent Psychiatry)
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2018 Category: Psychiatry Authors: Iliyan Ivanov, Kevin M. Gray Tags: Institute 7 Source Type: research

7.1 Epidemiology of Substance Use Disorders Among Youth and Parents
Child and adolescent psychiatrists need to be aware of the prevalence of substance use and substance use disorders (SUDs) in adolescence, young adulthood, and pregnancy, and among parents to identify SUDs in the children and families they treat. Child and adolescent psychiatrists also need to understand the prevalence of engagement in SUD treatment across the lifespan. Child and adolescent psychiatrists need to understand demographic differences in substance use/SUD and engagement in SUD treatment. (Source: Journal of the American Academy of Child and Adolescent Psychiatry)
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2018 Category: Psychiatry Authors: Amy Yule Source Type: research

7.2 High Times for Cannabis: Epigenetic Imprint and Its Legacy on Brain and Behavior
The reduced perception regarding risks associated with marijuana (Cannabis sativa), as well as the growing industry evolving around recreational and medical cannabis, has led to increased use of the drug, and is now used to a greater extent than cigarettes by adolescents. In this presentation, I will provide an overview of our findings regarding the vulnerabilities of the developing brain to cannabis exposure during particularly sensitive windows of development and its epigenetic legacy later in life. (Source: Journal of the American Academy of Child and Adolescent Psychiatry)
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2018 Category: Psychiatry Authors: Henrietta Szutorisz Source Type: research

7.3 Neurobiology of Substance Use Disorder Risk and Initial Exposure to Drugs
As more has been learned about the neurobiology of substance use disorders (SUDs) in adults, investigations in children at risk before exposure to abusable substances remain limited. As evidence points out that early experimentation with drugs may be linked to higher rates of later SUD, the mechanisms by which early drug exposure may influence the development of SUD still remain poorly understood. Furthermore, new evidence suggests that deficits in reward processing in the brain may represent putative predispositions for SUD development in youth. (Source: Journal of the American Academy of Child and Adolescent Psychiatry)
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2018 Category: Psychiatry Authors: Iliyan Ivanov Source Type: research

7.4 Substance Use in Pregnancy and Its Impact on Child Development
Substance use during pregnancy has a significant negative impact on maternal, fetal, newborn and child health. Although few randomized controlled trials for the treatment of perinatal substance use disorder (SUD) exist, it is important to know what treatments are available for pregnant women and how to counsel women about the risks of substance use, as well as the risks and potential benefits of available treatment options. (Source: Journal of the American Academy of Child and Adolescent Psychiatry)
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2018 Category: Psychiatry Authors: Constance Guille Source Type: research

7.5 Psychotherapies for Substance Use Disorders in Youth
Evidenced-based psychotherapies are foundational in the treatment of any substance use disorder (SUD). Despite research demonstrating effectiveness, adoption of evidenced-based psychotherapies is hardly uniform. Many medical providers are underinformed and undertrained in the use of these interventions. (Source: Journal of the American Academy of Child and Adolescent Psychiatry)
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2018 Category: Psychiatry Authors: Joseph S. Lee Source Type: research

7.6 The Impact of Parents and Family in the Prevention and Treatment of Adolescent Substance Use Disorders: Developmental and Transgenerational Perspectives
Despite a strong evidence base, family-based interventions for adolescent substance use disorders (SUDs) can be underappreciated in clinical practice and underemphasized in training. Treatment focused solely on individual interventions for an adolescent struggling with substance use represents a missed opportunity for more impactful and lasting improvement in symptoms of SUD. Both genetic and environmental factors contribute to the perpetuation of SUDs in a multigenerational pattern. Developmentally informed, family-based intervention at any stage in an individual and family ’s life cycle can represent not only treat...
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2018 Category: Psychiatry Authors: Peter Jackson Source Type: research

7.7 Pharmacotherapies for Youth Substance Use Disorder: Rationale, Evidence-Base, and Practical Strategies
Substance use disorders (SUDs) are prevalent and impairing across the lifespan. Psychosocial interventions remain the cornerstone of SUD treatment, but long-term abstinence outcomes are limited. Amid advances in characterizing the neurobiology of SUD, a number of pharmacotherapies have been developed and several currently have US FDA approval in adults. Application of these medications to adolescents with SUD has been less well-studied, but a number of recent randomized controlled trials may provide guidance for clinicians treating adolescents with SUD. (Source: Journal of the American Academy of Child and Adolescent Psychiatry)
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2018 Category: Psychiatry Authors: Kevin M. Gray Source Type: research

Coordinated Specialty Care for First-Episode Psychosis
The goal of this Symposium is to review the implementation, outcomes, and clinical correlates of coordinated specialty care programs for treating the first episode of psychosis. (Source: Journal of the American Academy of Child and Adolescent Psychiatry)
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2018 Category: Psychiatry Authors: Jon M. McClellan Tags: Symposium 1 Source Type: research

1.1 Washington State New Journeys Program for Young Adults Experiencing First-Episode Psychosis: Implementation and Outcomes
The goals of this session are to implement and evaluate treatment outcomes of Washington State ’s New Journeys program, a coordinated specialty care early intervention program for treating first-episode psychosis. (Source: Journal of the American Academy of Child and Adolescent Psychiatry)
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2018 Category: Psychiatry Authors: Maria Monroe-DeVita Source Type: research

1.2 Racial Differences in First-Episode Psychosis Treatment Outcomes: Data From the National RA1SE Early Treatment Program (ETP) Study
This study examined racial differences in treatment outcomes among participants enrolled in a large multisite, randomized controlled trial evaluating a coordinated specialty care model for first-episode psychosis called NAVIGATE. (Source: Journal of the American Academy of Child and Adolescent Psychiatry)
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2018 Category: Psychiatry Authors: Oladunni Oluwoye Source Type: research

1.3 The Impact of Tobacco, Alcohol, and Cannabis Use on Treatment Outcomes Among Patients Experiencing First-Episode Psychosis: Data From the National RA1SE Early Treatment Program (ETP) Study
The goal of this session is to examine the effect of recent tobacco, alcohol, and cannabis use on treatment outcomes among participants experiencing first-episode psychosis (FEP); these participants were enrolled in a large multisite clinical trial called Recovery After an Initial Schizophrenia Episode —Early Treatment Program (RAISE-ETP). (Source: Journal of the American Academy of Child and Adolescent Psychiatry)
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2018 Category: Psychiatry Authors: Michael McDonell Source Type: research

1.4 Implementing the Navigate Model for First-Episode Psychosis
The goals of this presentation are as follows: 1) to review the treatment components of the NAVIGATE model for treating first-episode psychosis; and 2) to describe the development and implementation of a first-episode psychosis clinic. (Source: Journal of the American Academy of Child and Adolescent Psychiatry)
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2018 Category: Psychiatry Authors: Krystal Ozanick Source Type: research

Maturation of Complex Cognition and the Risk for Psychopathology in Transition-Age Youth
This Symposium will focus on neurodevelopmental maturation occurring in transition-age youth (TAY), implications for mental health, and efforts to use cognitive subtypes in TAY with psychopathology to drive clinical/treatment innovation. (Source: Journal of the American Academy of Child and Adolescent Psychiatry)
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2018 Category: Psychiatry Authors: Stephanie Hope Ameis, Jeremy Veenstra-VanderWeele Tags: Symposium 2 Source Type: research